对心力衰竭的正气道压力疗法:试验告诉我们什么?
1Department of Internal Medicine II, University Hospital Regensburg Regensburg, Germany.
Cardiac failure review
|December 25, 2025
概括
阳性气道压力 (PAP) 治疗心力衰竭 (HF) 睡眠呼吸障碍 (SDB) 可能有利于特定的患者表型. 需要个性化治疗以优化结果,因为广泛的益处尚不清楚.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 睡眠呼吸障碍 (SDB) 在心力衰竭 (HF) 中很常见,是治疗的目标.
- 阳性气道压力 (PAP) 疗法已经发展,但并没有始终显示出死亡率或HF入院益处.
- 目前PAP的使用主要集中在SDB症状控制上,但安全性更好地理解.
研究的目的:
- 审查各种HF表型的SDB患者PAP治疗的证据.
- 突出需要基于表型的个性化治疗方法.
- 为了探索PAP治疗响应性的患者分层.
主要方法:
- 现有随机对照试验和临床数据的叙述性审查.
- 对不同心力衰竭和睡眠呼吸暂停表型的PAP治疗疗效的分析.
- 讨论个性化的治疗策略.
主要成果:
- 随机试验显示PAP治疗对HF死亡率和住院治疗的益处不一致.
- 在SDB症状管理中,PAP治疗通常是安全有效的.
- 根据表型的患者分层可以确定对PAP治疗的响应者.
结论:
- 在HF中治疗SDB的PAP治疗需要个性化,以表型为导向的方法.
- 需要进一步的研究来确定哪些HF患者从PAP治疗中获益最多.
- 优化PAP治疗可以改善SDB症状控制和选择高风患者的潜在临床结果.
相关概念视频
Mechanical Ventilation III: Noninvasive Ventilation
479
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
479
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
549
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
549
Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
Heart Failure Drugs: β-Blockers
727
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
727
Heart Failure V: Medical Management
196
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
196
Acute Respiratory Failure-V
413
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
413


